Family · Pharmaceutical analytical standards
Lorcaserin
A selective serotonin 5-HT2C receptor agonist, approved in the United States in 2012 for weight management in adults with obesity or overweight; it was withdrawn from the market in 2020. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?By activating 5-HT2C receptors in the hypothalamus it is thought to stimulate the production of POMC, linked to the feeling of fullness; it is about 100 times more selective for this receptor than for the similar 5-HT2B.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
